Business Profile

Description: Ionetix Corporation is a pioneering radiopharmaceutical end to end solutions provider for cardiac PET. We are changing the paradigm when it comes to access to one of the most accurate PET imaging agents for the detection of coronary artery disease, N-13 Ammonia. Until now, this tracer was only available to a select group of institutions due to its very short half-life and the need for a large and expensive cyclotron on site. Ionetix can now provide virtually any hospital or private center with on demand N-13 Ammonia doses without the need to purchase a cyclotron!